ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
AzurRx BioPharma Inc

AzurRx BioPharma Inc (AZRX)

3.45
0.00
(0.00%)
Closed September 24 4:00PM
3.45
0.00
( 0.00% )
Pre Market: 8:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
3.45
Bid
3.41
Ask
3.51
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
3.45
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
13,500,000
Dividend Yield
-
PE Ratio
-2.48
Earnings Per Share (EPS)
-1.19
Revenue
-
Net Profit
-16.1M

About AzurRx BioPharma Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
-

AZRX Latest News

AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today

BOCA RATON, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX) (“First Wave” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...

AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma

BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...

AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications

AzurRx BioPharma to be renamed “First Wave BioPharma” and trade under new NASDAQ ticker symbol, “FWBI” Three IBD clinical indications, including ulcerative colitis and Crohn’s disease, added to...

AzurRx BioPharma Announces Reverse Stock Split

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the...

AzurRx BioPharma Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

BOCA RATON, Fla., Sept. 10, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic...

AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

Review of Interim Safety Data Concluded with Favorable Recommendation to Continue RESERVOIR Trial as Planned Part 2 of RESERVOIR Trial to Enroll Up to 150 Patients to Evaluate Efficacy of FW-1022...

AzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

BOCA RATON, Fla., Sept. 07, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted...

AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)

MS1819 and PERT combination therapy achieves primary and secondary outcome measure endpointsStudy data indicates clinically meaningful improvement in coefficient of fat absorption (CFA) primary...

AzurRx BioPharma Announces WHO Publication of “Adrulipase Alfa” as International Nonproprietary Name for MS1819

BOCA RATON, Fla., Aug. 17, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted...

AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) (NASDAQ: AZRX), a company specializing in the development of targeted non-systemic...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSGMMotorsport Games Inc
$ 1.43
(30.00%)
2.33M
VSMEVS Media Holdings Ltd
$ 1.58
(28.46%)
1.85M
ELYMEliem Therapeutics Inc
$ 8.38
(27.74%)
236.57k
XHGXChange TED Inc
$ 1.45
(20.83%)
963.67k
FRZAForza X1 Inc
$ 0.33
(17.82%)
20
VTNRVertex Energy Inc
$ 0.1476
(-59.11%)
841.27k
PLBYPLBY Group Inc
$ 0.53
(-26.40%)
74
PTIXProtagenic Therapeutics Inc
$ 0.46
(-23.46%)
5
SFIXStitch Fix Inc
$ 2.90
(-22.67%)
11.51k
NRSNNeuroSense Therapeutics Ltd
$ 1.01
(-19.20%)
635
ELABElevai Labs Inc
$ 0.1088
(5.63%)
4.07M
MTCMMTec Inc
$ 0.2902
(1.61%)
2.73M
MSGMMotorsport Games Inc
$ 1.43
(30.00%)
2.33M
VSMEVS Media Holdings Ltd
$ 1.58
(28.46%)
1.85M
XHGXChange TED Inc
$ 1.45
(20.83%)
963.67k

Discussion

View Full Feed
EOT EOT 6 minutes ago
How did you find that….hilarious!!
KBLB
benyam benyam 9 minutes ago
nice update wpp yesterday on x
BOPO
Iggy_Bot Iggy_Bot 11 minutes ago
Agree 110% It's out in the open for all to see...
maumar maumar 14 minutes ago
It looks like Halo dodged a bullet with Amgen Uplizna data showing efficacy below Vyvgart, so it is not deemed a threat for now. In fact, JPM: “overhang cleared, we would buy Argenx for CIDP launch upside.”
JPM
SkeBallLarry SkeBallLarry 15 minutes ago
" I hope Mr. Trump starts being more careful >

It's openly obvious, they mean business " .. !!
diggitydoodle diggitydoodle 20 minutes ago
Halfway through another week, and as usual...
FOXO with very little movement, and still trying to just get back to where it was before the great deal was done.
And, RNVA is frozen at doing nothing.
RNVA shareholders are limited in info because all the attention is on FOXO, and
FOXO RNVA
sylvia07 sylvia07 24 minutes ago
Yes, you are right, Bashers ball, now!
DBMM
Iggy_Bot Iggy_Bot 25 minutes ago
Trump made 2 great speeches yesterday.
Retire43 Retire43 31 minutes ago
Peer reviewed

https://finance.yahoo.com/news/bioxytrans-medical-breakthrough-fighting-viruses-133500730.html/
BIXT
RuudSaltis RuudSaltis 33 minutes ago
You asked to update the latest fintel short figure. Here it is :20,370,986 .
ASTS
Retire43 Retire43 35 minutes ago
Look at this


Cytta Corp
cytta.com
$CYCA
Thus company is beginning to generate revenue!

https://smallcapvip.com/investing-in-safety-how-personal-security-technologies-like-cyttacares-and-bsafe-are-shaping-the-future/
CYCA
RuudSaltis RuudSaltis 35 minutes ago
Fintel latest short count: 20,370,986 . So approx 400.00 less.
LWLG
Retire43 Retire43 37 minutes ago
http://www.marketwired.com/press-release/smartmetric-inc-vs-mastercard-visa-in-134-billion-patent-infringement-case-otcqb-smme-1822248.htm
SMME
tw0122 tw0122 42 minutes ago
Pump and dump
ATCH
Murphydog25 Murphydog25 44 minutes ago
🤦‍♂️
TXTM
Ribo Ribo 46 minutes ago
https://x.com/OtcUpdates/status/1838791326235558166
BDPT
CanItBThisEZ2Make CanItBThisEZ2Make 51 minutes ago
$AZRH IS NOW PINK CURRENT ====>
https://www.otcmarkets.com/stock/AZRH/overview

GO AZRH$
AZRH
thistraderknowsall thistraderknowsall 56 minutes ago
NKN altcoin explodes exponentially to $1+ South Korea’s central bank, the Bank of Korea, will soon allow participants to use digital tokens for payments at supermarkets and convenience stores.
Den Den 59 minutes ago
I don’think so … low volume … we’ll be back up fast…. If pr train starts … we’ll be off to the races …
Bring it on Dave 😊

Go $BLEG
BLEG
gregcod gregcod 1 hour ago
Yes Tom16 and you are right...SomethinIm not selling any shares and who in their right mind would?..Scared newbees possibly..but we longs know what we own..We want the results of the testing being done currently at the US Mag plant, plus any other good news..Whats up doc?..Iris?...Has to come soon.I
IBATF
TRUISM TRUISM 1 hour ago
Harvest will be very telling indeed...

Reminiscent of 2013-2023:

https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Ftse1.mm.bing.net%2Fth%3Fid%3DOIP.UQao-xwVjeiLNIAt_UTJywHaFj%26pid%3DApi&f=1&ipt=6ad1ffb6b96cb0269b4044cdb68a34671682d3b4cd3d9562ac229a80e4f4a0f8
KBLB
misterfishman misterfishman 1 hour ago
I hope your dreams come true you have waited long enough.
IGPK
nowwhat2 nowwhat2 1 hour ago
This here is NEWS........It's NOT me "on a pulpit"
It's BITCOINS' REACTION TO its' 200 day moving average


https://investorshub.advfn.com/uimage/uploads/2024/9/25/geyemIHUB_PULPIT_SHELLY.jpg




The board is for discussion.....
BTCUSD
DR_rugby DR_rugby 1 hour ago
Did you buy and hodl?

https://m.youtube.com/watch?v=N8AGt4_P4Ys

Infinite risk

GLTA
GME
TRUSTUNITS1000000 TRUSTUNITS1000000 1 hour ago
A while back 0.0001 to under .10
FMNJ

Your Recent History

Delayed Upgrade Clock